Showing 1 - 6 results of 6 for search 'Xiang-Cheng Li', query time: 0.04s Refine Results
  1. 1
    Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study

    Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study by Gu-Wei Ji, Fei-Peng Zhu, Qing Xu, Ke Wang, Ming-Yu Wu, Wei-Wei Tang, Xiang-Cheng Li, Xue-Hao Wang

    Published 2019-12-01
    Get full text
    Article
  2. 2
    Translating imaging traits of mass-forming intrahepatic cholangiocarcinoma into the clinic: From prognostic to therapeutic insights

    Translating imaging traits of mass-forming intrahepatic cholangiocarcinoma into the clinic: From prognostic to therapeutic insights by Gu-Wei Ji, Qing Xu, Chen-Yu Jiao, Ming Lu, Zheng-Gang Xu, Biao Zhang, Yue Yang, Ke Wang, Xiang-Cheng Li, Xue-Hao Wang

    Published 2023-10-01
    Get full text
    Article
  3. 3
    BUB1B promotes extrahepatic cholangiocarcinoma progression via JNK/c-Jun pathways

    BUB1B promotes extrahepatic cholangiocarcinoma progression via JNK/c-Jun pathways by Chen Yu Jiao, Qin Chao Feng, Chang Xian Li, Dong Wang, Sheng Han, Yao Dong Zhang, Wang Jie Jiang, Jiang Chang, Xuehao Wang, Xiang Cheng Li

    Published 2021-01-01
    Get full text
    Article
  4. 4
    Apolipoprotein A-1 Accelerated Liver Regeneration Through Regulating Autophagy Via AMPK-ULK1 PathwaySummary

    Apolipoprotein A-1 Accelerated Liver Regeneration Through Regulating Autophagy Via AMPK-ULK1 PathwaySummary by Zi Yi Wang, Rui Xiang Chen, Ji Fei Wang, Shuo Chen Liu, Xiao Xu, Tao Zhou, Yan An Lan Chen, Yao Dong Zhang, Xiang Cheng Li, Chang Xian Li

    Published 2024-01-01
    Get full text
    Article
  5. 5
    CircUGP2 Suppresses Intrahepatic Cholangiocarcinoma Progression via p53 Signaling Through Interacting With PURB to Regulate ADGRB1 Transcription and Sponging miR‐3191‐5p

    CircUGP2 Suppresses Intrahepatic Cholangiocarcinoma Progression via p53 Signaling Through Interacting With PURB to Regulate ADGRB1 Transcription and Sponging miR‐3191‐5p by Rui Xiang Chen, Shuo Chen Liu, Xue Chun Kan, Yi Rui Wang, Ji Fei Wang, Tian Lin Wang, Chang Li, Wang Jie Jiang, Yan An Lan Chen, Tao Zhou, Shi Long Fan, Jiang Chang, Xiao Xu, Kuang Heng Shi, Yao Dong Zhang, Ming Yu Wu, Yue Yu, Chang Xian Li, Xiang Cheng Li

    Published 2024-10-01
    Get full text
    Article
  6. 6
    Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II study

    Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II study by Guo‐Ming Shi, Xiao‐Yong Huang, Tian‐Fu Wen, Tian‐Qiang Song, Ming Kuang, Hai‐Bo Mou, Le‐Qun Bao, Hai‐Tao Zhao, Hong Zhao, Xie‐Lin Feng, Bi‐Xiang Zhang, Tao Peng, Yu‐Bao Zhang, Xiang‐Cheng Li, Hong‐Sheng Yu, Yu Cao, Lian‐Xin Liu, Ti Zhang, Wei‐Lin Wang, Jiang‐Hua Ran, Ying‐Bin Liu, Wei Gong, Ming‐Xia Chen, Lian Cao, Yang Luo, Yan Wang, Hui Zhou, Guo‐Huan Yang, Jia Fan, Jian Zhou

    Published 2023-02-01
    Get full text
    Article

Search Tools: